Masimo | MASI - Sales Revenues


Masimo reported $412.5M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Accuray USD 116.17M 14.63M Dec/2024
Align Technology USD 1.05B 54.3M Dec/2025
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 140.5M 6.2M Dec/2025
Avanos Medical USD 180.9M 3.1M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Boston Scientific USD 5.2B 90M Mar/2026
Dexcom USD 1.26B 50M Dec/2025
Edwards Lifesciences USD 1.65B 80M Mar/2026
General Electric Aerospace USD 11.6B 270M Mar/2026
Globus Medical USD 826.4M 57.4M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Inogen USD 74.93M 504K Sep/2024
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
Intuitive Surgical USD 2.77B 100M Mar/2026
Masimo USD 412.5M 41M Dec/2025
Medtronic USD 9B 39M Jan/2026
Orthofix International USD 219.91M 14.28M Dec/2025
Owens Minor USD 708.97M 11.71M Dec/2025
ResMed USD 1.4B 100M Dec/2025
Steris USD 1.5B 470M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025